¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"benign prostatic hypertrophy"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • prostatic concretion
    Àü¸³»ùµ¹, Àü¸³¼±°á¼®
  • prostatic ductule
    Àü¸³»ù¼¼°ü
  • prostatic fluid
    Àü¸³»ù¾×, Àü¸³¼±¾×
  • prostatic intraepithelial neoplasia
    Àü¸³»ù»óÇdz»Á¾¾ç, Àü¸³¼±»óÇdz»Á¾¾ç
  • prostatic massage
    Àü¸³»ù¸¶»çÁö
  • prostatic sinus
    Àü¸³»ù±¼, Àü¸³¼±µ¿
  • prostatic utricle
    Àü¸³»ù¼Ò½Ç
  • asymmetric septal hypertrophy
    ºñ´ëĪÁ߰ݺñ´ë, ºñ´ëĪ»çÀ̸·ºñ´ë
  • anabolic hypertrophy
    µ¿È­ºñ´ë
  • compensatory hypertrophy
    º¸»óºñ´ë
  • concentric hypertrophy
    µ¿½Éºñ´ë
  • denture hypertrophy
    ÀÇÄ¡Á¶Á÷ºñ´ë
  • false hypertrophy
    °ÅÁþºñ´ë
  • gum hypertrophy
    ÀÕ¸öºñ´ë
  • hypertrophy
    ºñ´ë
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • benign papular acantholytic dermatosis
    ¾ç¼º±¸Áø°¡½Ã¼¼Æ÷ÇØ¸®ÇǺκ´
  • hereditary benign intraepithelial dyskeratosis
    À¯Àü¾ç¼º»óÇdz»ÀÌ»ó°¢È­Áõ
  • anabolic hypertrophy
    µ¿È­ºñ´ë
  • asymmetric septal hypertrophy
    ºñ´ëĪÁ߰ݺñ´ë, ºñ´ëĪ»çÀ̸·ºñ´ë
  • cicatricial hypertrophy
    ¹ÝÈ缺ºñ´ë, ÈäÅͺñ´ë
  • combined ventricular hypertrophy
    º¹ÇսɽǺñ´ë
  • compensatory hypertrophy
    º¸»óºñ´ë
  • concentric hypertrophy
    µ¿½Éºñ´ë
  • denture hypertrophy
    ÀÇÄ¡Á¶Á÷ºñ´ë
  • false hypertrophy
    °ÅÁþºñ´ë
  • hypertrophy
    ºñ´ë
  • idiopathic myocardial hypertrophy
    Ư¹ß½É±Ùºñ´ë, ¿øÀκҸí½É±Ùºñ´ë
  • papillomatous hypertrophy
    À¯µÎÁ¾¸ð¾çºñ´ë
  • physiologic hypertrophy
    »ý¸®Àûºñ´ë
  • pseudomuscular hypertrophy
    °ÅÁþ±ÙÀ°ºñ´ë
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • hypertrophy, compensatory
    ´ë»ó¼º ºñ´ë.
  • hypertrophy, ventricular
    ½É½ÇºñÈÄ.
  • hypertrophy,asymmetric septal
    ºñ´ëμº Áß°Ý
  • idiopathic myocardial hypertrophy
    Ư¹ß¼º ½É±Ùºñ´ëÁõ.
  • physiologic hypertrophy
    »ý¸®Àû ºñ´ë (¡­îÜÝþÓÞ).
  • physiologic hypertrophy
    »ý¸®Àû ºñ´ë(ßæ×âîÜ ÝþÓÞ)
  • prostatic
    Àü¸³¼±(îñí¡àÍ)ÀÇ.
  • prostatic
    Àü¸³¼±ÀÇ
  • prostatic abscess
    Àü¸³¼±³ó¾ç(¡­ÒÛåË).
  • prostatic abscess
    Àü¸³¼±³ó¾ç(îñí¡àÍÒÛåË)
  • prostatic acid phosphatase
    Àü¸³¼±»êÀλêÈ¿¼Ò(Æ÷½ºÆÄŸÁ¦)(îñí¡àÍß«×òß«ý£áÈ)
  • prostatic adenoma
    Àü¸³¼±¼±Á¾
  • prostatic artery
    Àü¸³¼±µ¿¸Æ
  • prostatic branches
    Àü¸³»ù°¡Áö
  • prostatic calculus
    Àü¸³¼±°á¼®(¡­Ì¿à´).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • benign mucosal pemphigoid
    ¾ç¼ºÁ¡¸·À¯ÃµÆ÷â
  • benign nephrosclerosis
    ¾ç¼º½Å°æÈ­Áõ(¡­ãìÌãûùñø).
  • benign neurocutaneous melanomatosis
    ¾ç¼º ½Å°æÇÇºÎ Èæ»öÁ¾Áõ
  • benign ovarian tumor
    ¾ç¼º³­¼ÒÁ¾¾ç
  • benign papular acantholytic dermatosis
    ¾ç¼º±¸Áø¼º ±Ø¼¼Æ÷ÇØ¸®ÇǺκ´
  • benign paroxysmal positional vertigo
    ¾ç¼º¹ßÀÛ(¼º)µÎÀ§Çö±â(Áõ)
  • benign paroxysmal positional vertigo
    ¾ç¼º üÀ§¼º µ¹¹ßÇöÈÆ
  • benign partial epilepsy of childhood
    ¼Ò¾Æ±â ¾ç¼ººÎºÐ°£Áú
  • benign symmetric lipomatosis
    ¾ç¼º ´ëμºÁö¹æÁ¾Áõ
  • familial benign chronic pemphigus
    °¡Á·¼º ¾ç¼º¸¸¼º õÆ÷â(¡­åÐàõØ·àõô¸øÞóê)
  • hereditary benign intraepithelial dyskeratosis
    À¯Àü¼º ¾ç¼º »óÇdz» ÀÌ»ó°¢È­Áõ
  • hypertension,benign nephrosclerosis
    ¾ç¼º ½Å°æÈ­Áõ
  • multiple benign cystic epithelioma
    ´Ù¹ß¼º ¾ç¼º ³¶Á¾¼º »óÇÇÁ¾
  • tumor, benign mixed
    ¾ç¼ºÈ¥ÇÕÁ¾, ´ÙÇü¼º¼±Á¾
  • tumor,benign
    ¾ç¼º
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
PAP   1) Prostatic Acid Phosphatase; Àü¸³¼º »ê¼º ÀλêºÐÇØÈ¿¼Ò
  2) Primary Atypical Pneumoni...
PSA Prostate(Prostatic)-Specific Antigen; Àü¸³¼± ƯÀÌ Ç׿ø
NPCP National Prostatic Cancer Project; non-Pneumocystis pneumonia
PAP pancreatitis-associated protein; Papanicolaou [test]; papaverine; passive-aggressive personality; pa...
PC avoirdupois weight [Lat. pondus civile]; packed cells; paper chromatography; paracortex; parent cell...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
ASH Asymmetrical septal hypertrophy
COH Compensatory ovarian hypertrophy
CHRPE Congenital hypertrophy of the retinal pigment epithelium
LVH LV hypertrophy
LVH Left Ventricular Hypertrophy
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • muscular hypertrophy
    ±ÙÀ° ºñ´ëÁõ, ±ÙÀ° ºñ´ë, ±Ù ºñ´ë
    ±Ù ºñ´ë´Â ±Ù ¼¶À¯ÀÇ Å©±âÀÇ Áõ°¡¸¦ ÀǹÌÇÑ´Ù. Áö¹æ ħÀ±, Á¾¾ç, ¿°Áõ¼º º´º¯¿¡ µû¸¥ ¿Ü°ß»ó ºñ´ë¸¦ °¡¼º ºñ´ë¶ó°í ÇÏ°í »ç½Ç»óÀÇ ºñ´ë¿Í ±¸º°ÇÑ´Ù. °Ç°­ÇÑ ±ÙÀ°µµ Àå±â¿¡ °ÉÄ£ °úÀ× ÀÛ¾÷À¸·Î ÀÎÇØ ºñ´ë¸¦ ÀÏÀ¸Å²´Ù. ÁøÇ༺ ±ÙÀÌ¿µ¾çÁõÀÇ °æ¿ì ºñÀå±ÙÀÇ ºñ´ë°¡ Á¾Á¾ ù Áõ»óÀÌ µÈ´Ù. ¼±Ãµ¼º ±Ù ±äÀåÁõ¿¡¼­µµ ±Ù ºñ´ë¸¦ º¸°Ô µÈ´Ù. ±Ù ºñ´ë¿¡´Â ³²¼º È£¸£¸ó µîÀÇ ³»ºÐºñ ÀÎÀÚµµ Áß¿äÇÑ ¿ªÇÒÀ» Áö´Ñ´Ù.
  • non-painful masticatory muscle hypertrophy
    ºñÅëÁõ¼º ÀúÀÛ±Ù ºñ´ë
  • pseudomuscular hypertrophy
    °¡±Ùºñ´ë, °¡¼º ±Ù ºñ´ë
  • right ventricular hypertrophy
    ¿ì ½É½Ç ºñ´ë
  • tonsillar hypertrophy
    Æíµµ ºñ´ë
    ±¸°³ ÆíµµÀÇ ºñ´ë. ´ëü·Î ÀεΠÆíµµ, ¼³±Ù Æíµµ, À̰ü ÆíµµÀÇ ºñ´ë¸¦ ¼ö¹ÝÇÏ´Â °æ¿ì°¡ ¸¹´Ù. ½Å»ý¾Æ¿¡¼­´Â ±×´ÙÁö º¼ ¼ö ¾øÁö¸¸, ¿¬·É Áõ°¡¿Í ÇÔ²² Ä¿Á® ÇзɱⰡ µÇ¸é ÃÖ´ë·Î µÇ°í, »çÃá±â ÀÌÈÄ¿¡´Â ÅðÇà À§ÃàÇÑ´Ù. ÀÌ¿Í °°Àº ¿¬·É¿¡ µû¸¥ ¹ßÀ° ÇüÅÂÀÇ ¿øÀÎÀº ¾ÆÁ÷ ¹àÇôÁöÁö ¾Ê¾Ò´Âµ¥ ÀÌ ¹ßÀ° ÇüŰ¡ ºñÁ¤»óÀÎ °æ¿ì, ¿¬ÇÏ¿Í È£Èí¿¡ Àå¾Ö¸¦ ÃÊ·¡ÇÑ´Ù. Áõ»óÀº 3µµ·Î ±¸ºÐµÇ´Âµ¥, 1µµ´Â ±×´ÙÁö ½ÉÇÏÁö ¾ÊÀº °æ¿ì, 2µµ´Â ±¸°³±ÃÀ» ³Ñ¾î ±¸°³ Æíµµ°¡ Àεΰ­ ¼ÓÀ¸·Î ¾î´À Á¤µµ µ¹ÃâÇÑ °æ¿ì, 3µµ´Â Á¿ìÀÇ ±¸°³ Æíµµ°¡ ¼­·Î Á¢ÃËÇÒ Á¤µµ·Î ºñ´ëÇÑ °æ¿ì¸¦ ¸»ÇÑ´Ù. 3µµÀÇ °æ¿ì, ¿Ü°úÀûÀ¸·Î ÀýÁ¦ÇØ¾ß ÇÒ Çʿ䰡 ÀÖ´Ù. ÀεΠÆíµµÀÇ ºñ´ë´Â ¾Æµ¥³ëÀ̵å Áõ½ÄÀ̶ó°í Çϴµ¥, ¾î¸°¾ÆÀÌ¿¡°Ô ¸¹°í ºñ È£ÈíÀÇ Àå¾Ö¸¦ ÀÏÀ¸Å²´Ù. ¼³±Ù Æíµµ ºñ´ë´Â ¼ºÀο¡°Ô ¸¹´Ù.
  • true hypertrophy
    Áø¼º ºñ´ë
  • unilateral hypertrophy
    ÇÑ ÂÊ ºñ´ë
  • vicarious hypertrophy
    ´ë»ó¼º ºñ´ë
  • zone of hypertrophy
    ºñ´ëÃþ
  • benign aphthae
    ¾ç¼º ¾ÆÇÁŸ
  • benign cementoblastoma
    ¾ç¼º ¹é¾Ç¸ð¼¼Æ÷Á¾, ¾ç¼º ¹é¾Ç¾Æ¼¼Æ÷Á¾
    1. ¸ðµç ¿¬·É¿¡¼­ »ó, ÇÏ, ÁÂ¿ì ¾çÃø¿¡¼­ µ¿½Ã¿¡ ¹ß»ý. Ä¡±Ù ÁÖÀ§¿¡ ¹é¾ÇÁúÀ̳ª ¹é¾ÇÁú¾ç Á¶Á÷ÀÇ µ¢¾î¸®¸¦ Çü¼ºÇÏ´Â ±â´ÉÀû Á¶¹é¾Ç¼¼Æ÷·Î ÀÌ·ç¾îÁø ¾ç¼º Á¾¾çÀÌ´Ù.
  • benign chondroblastoma
    ¾ç¼º ¿¬°ñ¾Æ¼¼Æ÷Á¾
    ¿¬°ñ¾Æ¼¼Æ÷ ¶Ç´Â ±× Àü±¸Ã¼·ÎºÎÅÍ ¹ß»ýµÇ¾î ¿¬°ñ¼¼Æ÷·Î ºÐÈ­µÇ´Â °æÇâÀ» °®´Â ¼¼Æ÷·Î ±¸¼ºµÈ ¾ç¼º Á¾¾çÀÌ´Ù.
  • benign cystic teratoma
    ¾ç¼º ±âÇüÁ¾
  • benign familial pemphigus
    ¾ç¼º °¡Á·¼º õÆ÷â
    µå¹°°Ô ¹ß»ýÇÏ´Â, À¯Àü¼ºÀ̸ç Áö¼ÓÀûÀ¸·Î Àç¹ßÀ» ¹Ýº¹ÇÏ´Â ¼ÒÆ÷¼º ¹× ÀÛÀº ¼öÆ÷¼º ÇǺο°À¸·Î, ¾×¿Í, ¼­ÇýºÎ ¹× ¸ñ ºÎÀ§¸¦ °¡Àå Àß Ä§¹üÇÏÁö¸¸, ¶§·Î´Â ±¤¹üÇÑ ºÎÀ§¸¦ ħ¹üÇÑ´Ù. º´º¯Àº ´Ù¹ß¼ºÀ̸ç, ¼öÁÖÀÏ ³»Áö ¼ö°³¿ù ÈÄ¿¡ ¼èÅðÇÑ´Ù. ÀÌ ÁúȯÀº »ó¿°»öü ¿ì¼º À¯ÀüÀ» ÇÑ´Ù.
  • benign giant cell tumor
    ¾ç¼º °Å´ë¼¼Æ÷ Á¾¾ç
    1. °ñÀÇ ¾ç¼º °Å´ë¼¼Æ÷Á¾. °ñÀÇ ¾ç¼º Á¾¾çÀÇ Çϳª·Î ³ë¾àÀÚ¿¡°Ô ¸¹À¸¸ç ¹ß»ý ºÎÀ§´Â Àå°ü°ñÀÇ °ñ´Ü¿¡ ¸¹ÀÌ ³ªÅ¸³­´Ù. Á¶Á÷ÇÐÀûÀ¸·Î ¿øÇü, ¹æÃßÇüÀÌ ÀÖ´Ù. ¼¼Æ÷ »çÀÌ¿¡ ÆÄ°ñ¼¼Æ÷¿Í À¯»çÇÑ °Å´ë¼¼Æ÷°¡ È¥ÀçÇÑ´Ù. 2. °ÇÃÊÀÇ ¾ç¼º °Å´ë¼¼Æ÷Á¾. º»·¡ Á¾¾çÀÌ ¾Æ´Ï¸ç, °áÁ¤¼º °ÇÃÊ¿°À» °¡¸®Å°¸ç °ÇÃÊÀÇ ¼¶À¯¼º Á¶Á÷±¸Á¾¿¡ Æ÷ÇԵȴÙ.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
prostatic urethra The prostatic part of the male urethra, about 2.5 cm in length, that traverses the prostate; it includes the seminal colliculus, and the ejaculatory and prostatic ducts open into it.
Synonym: pars prostatica urethrae.
(05 Mar 2000)
prostatic utricle A minute pouch in the prostate opening on the summit of the seminal colliculus, the analogue of the uterus and vagina in the female, being the remains of the fused caudal ends of the paramesonephric ducts.
Synonym: utriculus prostaticus, masculine uterus, Morgagni's sinus, sinus pocularis, uterus masculinus, vagina masculina, vesica prostatica, Weber's organ.
(05 Mar 2000)
prostatic venous plexus A venous plexus, arising chiefly from the dorsal vein of the penis, situated below the base of the bladder at the sides of the prostate.
See: prostaticovesical plexus.
Synonym: plexus venosus prostaticus, plexus pudendalis, Santorini's labyrinth.
(05 Mar 2000)
Young prostatic tractor A short, straight tubular instrument with blades at its tip, which can be rotated open and closed; it is passed into the prostatic urethra, through a prostatotomy incision made during the later stages of open perineal prostatectomy, with its tip into the bladder; direct traction on the instrument brings the prostate gland down into the operative field where enucleation can be more easily performed.
(05 Mar 2000)
adaptive hypertrophy Thickening of the walls of a hollow organ, like the urinary bladder, when there is obstruction to outflow.
(05 Mar 2000)
giant hypertrophy of gastric mucosa Gastric mucosal hyperplasia, either mucoid or glandular; the latter type may be associated with the Zollinger-Ellison syndrome.
Synonym: giant hypertrophy of gastric mucosa, hypertrophic gastritis, Menetrier's syndrome.
(05 Mar 2000)
gingival hypertrophy <dentistry> The abnormal enlargement of the gingiva surrounding the teeth caused by poor oral hygiene.
(08 Jan 1998)
vicarious hypertrophy Hypertrophy of an organ following failure of another organ because of a functional relationship between them; e.g., enlargement of the pituitary gland, after destruction of the thyroid.
(05 Mar 2000)
right ventricular hypertrophy <radiology> Pulmonary valve stenosis, pulmonary hypertension, tetralogy of Fallot, VSD
(12 Dec 1998)
physiologic hypertrophy Temporary increase in size of an organ or part to provide for a natural increase of function, such as the kind that occurs in the walls of the uterus and in the mammae during pregnancy.
Synonym: functional hypertrophy.
(05 Mar 2000)
compensatory hypertrophy Increase in size of an organ or part of an organ or tissue, when called upon to do additional work or perform the work of destroyed tissue or of a paired organ.
(05 Mar 2000)
compensatory hypertrophy of the heart Thickening of the walls of the heart in response to vascular, valvular, other heart disease, or athletic conditioning.
(05 Mar 2000)
complementary hypertrophy Increase in size or expansion of part of an organ or tissue to fill the space left by the destruction of another portion of the same organ or tissue.
(05 Mar 2000)
concentric hypertrophy Thickening of the walls of the heart or any cavity with apparent diminution of the capacity of the cavity.
(05 Mar 2000)
haemangiectatic hypertrophy <syndrome> A congenital malformation syndrome characterised by the triad of asymmetric limb hypertrophy, haemangiomata, and nevi. Asymmetric limb hypertrophy is enlargement of one limb and not the corresponding limb on the other side, the enlarged limb being 3 times more likely to be a leg than an arm in ktw; and the limb enlargement is of bone as well as soft tissue. The haemangiomas, abnormal nests of blood vessels that proliferate inappropriately and excessively, cover a remarkable range from small innocuous capillary haemangiomas ( strawberry marks ) to huge cavernous haemangiomas. The nevi are pigmented moles on the skin; in ktw there are often also dark linear streaks on the skin, streaks due to too much pigment. There can be other abnormalities but the triad is the consistent clinical centrepiece of the disease. most persons with ktw have an enlarged leg and do relatively well without treatment or, for example, with only compression from an elastic stocking. Skin ulcers and other skin problems can occur over the swollen leg. Usually, the treatment is conservative. Surgery is almost never needed. The only possible exceptions are the very rare situations in which the leg reaches gigantic proportions or secondary clotting difficulties arise (due to trapping and destruction of blood platelets in a huge haemangioma). Then, amputation may become necessary. The cause of ktw syndrome is unknown.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á